Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

Eli Lilly · Phase 1 · Completed · Enrollment 50

NCT06186622

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Cohort 1: Oral Drug Dosing With or Without Orforglipron Co-Administrationn/rn/rn/rn/rn/r
Cohort 2: Oral Drug Dosing With or Without Orforglipron Co-Administrationn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.